Epigallocatechin-3-gallate (EGCG): Matrix-metalloproteinase 7 (MMP7) is expressed at increased levels in the skin of RDEB patients, where it contributes to the degradation of C7 [78]. Here, MMP7 is linked to recessive dystrophic epidermolysis bullosa.